Workflow
Globenewswire
icon
Search documents
Pet Valu Paw-tners with Tim Hortons ® on Roll Up To Win™
Globenewswire· 2026-02-23 12:02
Pet Valu’s family of stores providing fifteen grand prizes of dry dog or cat food for one year and 17,000 $15 in store e-gift cards MARKHAM, Ontario, Feb. 23, 2026 (GLOBE NEWSWIRE) -- For the first time since Tim Hortons launched Roll Up To Win™ 40 years ago, Canadians playing the iconic contest will have the chance to win Pet Valu prizes for their pets. Pet Valu, Canada’s leading specialty retailer of pet food and pet-related supplies, announced today that it is the contest’s first-ever pet retail prize pa ...
Pet Valu Paw-tners with Tim Hortons ® on Roll Up To Win™
Globenewswire· 2026-02-23 12:02
MARKHAM, Ontario, Feb. 23, 2026 (GLOBE NEWSWIRE) -- For the first time since Tim Hortons launched Roll Up To Win™ 40 years ago, Canadians playing the iconic contest will have the chance to win Pet Valu prizes for their pets. Pet Valu, Canada’s leading specialty retailer of pet food and pet-related supplies, announced today that it is the contest’s first-ever pet retail prize paw-tner for Roll Up To Win™. Devoted pet (and coffee) lovers have a chance to win one of 15 grand prizes of free dry dog or cat food ...
Westhaven Gold and Dundee Corporation Announce Closing of Strategic $85M Earn-In Agreement to Advance Shovelnose and the Spences Bridge Gold Belt, British Columbia
Globenewswire· 2026-02-23 12:00
VANCOUVER, British Columbia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Westhaven Gold Corp. (TSX–V: WHN) (OTCQB: WTHVF) (“Westhaven” or the “Company”) and Dundee Corporation (TSX: DC.A) (“Dundee”) are pleased to announce the effectiveness of the definitive earn-in agreement (the “Earn-In Agreement”) granting Dundee the sole and exclusive right to acquire up to a 60% interest in Westhaven’s Shovelnose Gold Project, Prospect Valley Gold Project, Skoonka Gold Project and Skoonka North Project located in the Spences Br ...
Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer
Globenewswire· 2026-02-23 12:00
WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that Ryan Maynard will join the company as Chief Financial Officer (CFO) on February 23, 2026. Mr. Maynard joins Foghorn with over 25 years of executive experience driving financial strategy, capital markets execution, and operational performance across publ ...
Axsome Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Globenewswire· 2026-02-23 12:00
Total 4Q and full year 2025 net product revenue of $196.0 million and $638.5 million, respectively,representing 65% and 66% year-over-year growth AUVELITY® 4Q and full year 2025 net product sales of $155.1 million and $507.1 million, respectively,representing 68% and 74% year-over-year growth SUNOSI® 4Q and full year 2025 net product revenue of $36.7 million and $124.8 million, respectively,representing 40% and 32% year-over-year growth SYMBRAVO® 4Q and full year 2025 net product sales of $4.1 million and $ ...
Electra Approves Construction Budget and Sets Schedule for Completion of its North American Cobalt Sulfate Refinery
Globenewswire· 2026-02-23 12:00
(All amounts in US$ unless otherwise stated) TORONTO, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) today announced that its Board of Directors has approved a $73 million construction budget and established an execution schedule to achieve mechanical completion of its cobalt sulfate Refinery north of Toronto, marking a significant step toward bringing North America’s first battery-grade cobalt refinery into operation. Commiss ...
Plug To Announce 2025 Fourth Quarter and Year-End Results
Globenewswire· 2026-02-23 12:00
SLINGERLANDS, N.Y., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the hydrogen economy, will announce its 2025 fourth quarter and year-end results on March 2, 2026. Join the call: Date: March 2, 2026Time: 4:30 PM ETToll-free: 877-407-9221 / +1 201-689-8597Direct webcast: https://event.webcasts.com/starthere.jsp?ei=1751318&tp_key=e18033c0ef The webcast can also be accessed directly from the Plug homepage (www.plugpower.com). A playba ...
TDG Discovers New ‘4300 Zone’ VMS Lens Below Former Hidden Creek Mine at Anyox Project
Globenewswire· 2026-02-23 12:00
VANCOUVER, British Columbia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- TDG Gold Corp. (TSXV: TDG | OTCQX: TDGGF) (the “Company” or “TDG”) is pleased to announce the discovery of a new lens (4300 Zone) of volcanogenic massive sulphide (“VMS”) Cu-Zn-Au-Ag-Co1 mineralization located below the past producing Hidden Creek Mine, at its 100% owned Anyox Project located, in the Golden Horseshoe of British Columbia. The Hidden Creek Mine was discovered in 1901 and operated between 1914-1935, with reported historical product ...
C4 Therapeutics Announces First Patient Dosed in Phase 2 MOMENTUM Trial of Cemsidomide, an Oral IKZF1/3 Degrader, in Combination with Dexamethasone for Relapsed/Refractory Multiple Myeloma
Globenewswire· 2026-02-23 12:00
Enrollment for Phase 2 MOMENTUM Trial Expected to Be Completed in Q1 2027 Phase 1b Trial of Cemsidomide in Combination with Elranatamab on Track to Initiate in Q2 2026 WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that the first patient has been dosed in the Phase 2 MOMENTUM trial evaluating cemsidomide in combination with dexamethasone fo ...
Loblaw to invest $2.4 billion in the Canadian economy in 2026, with plans to build 70 new stores and create well over 9,000 jobs
Globenewswire· 2026-02-23 12:00
The investment is part of a 5-year plan to invest $10 billion in Canadian communities by 2030BRAMPTON, Ontario, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Today, Loblaw Companies Limited (TSX: L, “Loblaw” or the “Company”), Canada’s food and pharmacy leader, announced that it will spend $2.4 billion in 2026 to expand and renovate its store network, enhance its supply chain capabilities, and create jobs for people all across Canada. At a time when Canadians are struggling with affordability and access to healthcare s ...